The SonoCiné Automated Whole-Breast Ultrasound System (AWBUS)
was designed specifically for Whole-Breast Ultrasound examinations
adjunctive to screening mammography for women with dense breast tissue.
Market Clearance and Approvals
–SonoCiné AWBUS has been cleared by the FDA as an adjunct to mammography (but not a replacement for screening mammography).
–SonoCiné AWBUS has been approved by Health Canada for breast cancer screening, 2011.
–SonoCiné AWBUS has been approved for breast cancer screening in 27 countries of the European Union, 2012.
–The SonoCiné technology and its application are protected by 7 U.S. and 14 international patents.
–There are 3 U.S. and 5 foreign patents pending.
SonoCiné AWBUS is an accessory to your own state-of-the-art ultrasound system.
–Does not require a dedicated room.
–Uses the transducer(s) of your existing ultrasound system.
–When SonoCiné is not in use your room and system are free for other uses.
SonoCiné AWBUS has been clinically tested and reported in a peer-reviewed published screening study (large, prospective, blinded, multicenter trial).
–European Radiology, March, 2010
Company’s Keywords:
health care, automated whole breast ultrasound, breast ultrasound, dense breast tissue
<10
<1364000
<2011